Prevalence of Legal, Prescription, and Illegal Drugs Aiming at Cognitive Enhancement across Sociodemographic Groups in Germany

References

• Adams, Kathleen K., William L. Baker, and Diana M. Sobieraj. 2020. “Myth Busters: Dietary Supplements and COVID-19.” The Annals of Pharmacotherapy 54(8):820–26. doi:10.1177/1060028020928052.
   PubMed Web of Science ®Google Scholar
• ADM. 2012. ADM-Forschungsprojekt‚ Dual-Frame-Ansätze’ 2011/2012. Forschungsbericht.
   Google Scholar
• Allen, Anita L. and Nicolle K. Strand. 2015. “Cognitive Enhancement and Beyond: Recommendations from the Bioethics Commission.” Trends in Cognitive Sciences 19(10):549–51. doi:10.1016/j.tics.2015.08.001.
   PubMed Web of Science ®Google Scholar
• Anon. 2021. “Perspektiven Der Schweizerischen Drogenpolitik. Bericht Des Bundesrates in Erfüllung Des Postulats 17.4076 Rechsteiner Paul, 12. Dezember 2017.” Retrieved May 11, 2022 (https://www.bag.admin.ch/bag/de/home/strategie-und-politik/politische-auftraege-und-aktionsplaene/drogenpolitik/perspektiven-drogenpolitik.html).
   Google Scholar
• Autor, David H. 2014. “Skills, Education, and the Rise of Earnings Inequality Among the ‘Other 99 Percent’.” Science 344(6186):843–51. doi:10.1126/science.1251868.
   PubMed Web of Science ®Google Scholar
• Bagusat, Christiana, Angela Kunzler, Jennifer Schlecht, Andreas G. Franke, Andrea Chmitorz, and Klaus Lieb. 2018. “Pharmacological Neuroenhancement and the Ability to Recover from Stress – A Representative Cross-Sectional Survey Among the German Population.” Substance Abuse Treatment, Prevention, and Policy 13(1):37. doi:10.1186/s13011-018-0174-1.
   PubMedGoogle Scholar
• Bard, Imre, George Gaskell, Agnes Allansdottir, Rui Vieira da Cunha, Peter Eduard, Juergen Hampel, Elisabeth Hildt, Christian Hofmaier, Nicole Kronberger, Sheena Laursen, et al. 2018. “Bottom Up Ethics – Neuroenhancement in Education and Employment.” Neuroethics 11(3):309–22. doi:10.1007/s12152-018-9366-7.
   PubMed Web of Science ®Google Scholar
• Baum, Myriam, Sebastian Sattler, and Mareike Reimann. 2023. “Towards an Understanding of How Stress and Resources Affect the Nonmedical Use of Prescription Drugs for Performance Enhancement Among Employees.” Current Psychology 42(6):4784–801. doi:10.1007/s12144-021-01873-7.
   Web of Science ®Google Scholar
• Bavelier, Daphne, Julian Savulescu, Linda P. Fried, Theodore Friedmann, Corinna E. Lathan, Simone Schürle, and John R. Beard. 2019. “Rethinking Human Enhancement As Collective Welfarism.” Nature Human Behaviour 3(3):204–06. doi:10.1038/s41562-019-0545-2.
   PubMed Web of Science ®Google Scholar
• Beckmann, Katharina, Axel Glemser, Christiane Heckel, Christian von der Heyde, Jürgen H. P. Hoffmeyer-Zlotnik, Ute Hanefeld, Robert Herter-Eschweiler, and Carola Kühnen. 2016. “Demographische Standards.” Statistik Und Wissenschaft 17 (6).
   Google Scholar
• Beddington, John, Cary L. Cooper, John Field, Usha Goswami, F. A. Huppert, R. Jenkins, H. S. Jones, Tom B. L. Kirkwood, B. J. Sahakian, S. M. Thomas, et al. 2008. “The Mental Wealth of Nations.” Nature 455(7216):1057–60. doi:10.1038/4551057a.
   PubMed Web of Science ®Google Scholar
• Bostrom, Nick and Anders Sandberg. 2009. “Cognitive Enhancement: Methods, Ethics, Regulatory Challenges.” Science and Engineering Ethics 15(3):311–41. doi:10.1007/s11948-009-9142-5.
   PubMed Web of Science ®Google Scholar
• Brand, Ralf and Helen Koch. 2016. “Using Caffeine Pills for Performance Enhancement. An Experimental Study on University Students’ Willingness and Their Intention to Try Neuroenhancements.” Frontiers in Psychology 7 (101). doi: 10.3389/fpsyg.2016.00101.
   Google Scholar
• Brühl, Annette B. and Barbara J. Sahakian. 2016. “Drugs, Games, and Devices for Enhancing Cognition: Implications for Work and Society.” Annals of the New York Academy of Sciences 1369(1):195–217. doi:10.1111/nyas.13040.
   PubMedGoogle Scholar
• Bundesinstitut für Risikobewertung. 2019. Kinder Und Jugendliche: Übermäßiger Konsum von Energy Drinks Erhöht Gesundheitsrisiko Für Herz Und Kreislauf. Bundesinstitut für Risikobewertung.
   Google Scholar
• Cabrera, Laura Yenisa. 2017. “Reframing Human Enhancement: A Population Health Perspective.” Frontiers in Sociology 2: 2. doi: 10.3389/fsoc.2017.00004.
   Google Scholar
• Campbell, Heather L., Madalina E. Tivarus, Ashleigh Hillier, and David Q. Beversdorf. 2008. “Increased Task Difficulty Results in Greater Impact of Noradrenergic Modulation of Cognitive Flexibility.” Pharmacology Biochemistry and Behavior 88(3):222–29. doi:10.1016/j.pbb.2007.08.003.
   PubMed Web of Science ®Google Scholar
• Carr, Deborah and Kristen W. Springer. 2010. “Advances in Families and Health Research in the 21st Century.” Journal of Marriage and Family 72(3):743–61. doi:10.1111/j.1741-3737.2010.00728.x.
   Web of Science ®Google Scholar
• Catherine, Coveney, Simon J. Williams, and Jonathan Gabe. 2019. “Enhancement Imaginaries: Exploring Public Understandings of Pharmaceutical Cognitive Enhancing Drugs.” Drugs: Education, Prevention & Policy 26(4):319–28. doi:10.1080/09687637.2019.1593318.
   Web of Science ®Google Scholar
• Caviola, Lucius and Nadira S. Faber. 2015. “Pills or Push-Ups? Effectiveness and Public Perception of Pharmacological and Non-Pharmacological Cognitive Enhancement.” Frontiers in Psychology 6:1852. doi:10.3389/fpsyg.2015.01852.
   PubMed Web of Science ®Google Scholar
• Caviola, Lucius, Adriano Mannino, Julian Savulescu, and Nadira Faulmüller. 2014. “Cognitive Biases Can Affect Moral Intuitions About Cognitive Enhancement.” Frontiers in Systems Neuroscience 8:195. doi:10.3389/fnsys.2014.00195.
   PubMedGoogle Scholar
• Celeste, Roger Keller and João Luiz Bastos. 2013. “Mid-Point for Open-Ended Income Category and the Effect of Equivalence Scales on the Income-Health Relationship.” Revista de Saude Publica 47(suppl 3):168–74. doi:10.1590/S0034-8910.2013047004388.
   PubMedGoogle Scholar
• Champagne, Jacqueline, Benjamin Gardner, and Eleanor J. Dommett. 2019. “Modelling Predictors of UK Undergraduates’ Attitudes Towards Smart Drugs.” Trends in Neuroscience and Education 14:33–39. doi:10.1016/j.tine.2019.02.001.
   PubMed Web of Science ®Google Scholar
• Conrad, Peter. 2007. The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders. Johns Hopkins University Press Baltimore.
   Google Scholar
• Coveney, Catherine and Jeanett Bjønness. 2019. Making Sense of Pharmaceutical Cognitive Enhancement: Taking Stock and Looking Forward. Vol. 26 Taylor & Francis.
   Google Scholar
• Crutzen, Rik and Anja Göritz. 2010. “Social Desirability and Self-Reported Health Risk Behaviors in Web-Based Research: Three Longitudinal Studies.” BMC Public Health 10(1):720. doi:10.1186/1471-2458-10-720.
   PubMed Web of Science ®Google Scholar
• DAK. 2009. “Gesundheitsreport 2009. Analyse Der Arbeitsunfähigkeitsdaten. Schwerpunktthema Doping Am Arbeitsplatz.” Berlin/Hamburg: DAK/IGES.
   Google Scholar
• d’Angelo, L‐S Camilla, George Savulich, and Barbara J. Sahakian. 2017. “Lifestyle Use of Drugs by Healthy People for Enhancing Cognition, Creativity, Motivation and Pleasure.” British Journal of Pharmacology 174(19):3257–67. doi:10.1111/bph.13813.
   PubMed Web of Science ®Google Scholar
• de Jongh, Reinoud. 2017. “Overclocking the Brain? The Potential and Limitations of Cognitionenhancing Drugs.” in Pp. 37–56 in Rethinking Cognitive Enhancement, edited by R. ter Meulen, A. Mohamed, and W. Hall. Oxford: Oxford University Press.
   Google Scholar
• DeSantis, A. D., E. M. Webb, and S. M. Noar. 2008. “Illicit Use of Prescription ADHD Medications on a College Campus: A Multimethodological Approach.” Journal of American College Health 57(3):315–24. doi:10.3200/JACH.57.3.315-324.
   PubMed Web of Science ®Google Scholar
• Die Bundesregierung. 2019. Koffein: Die Dosis Macht’s.
   Google Scholar
• Dinh, Claire T., Stacey Humphries, and Anjan Chatterjee. 2020. “Public Opinion on Cognitive Enhancement Varies Across Different Situations.” American Journal of Bioethics – Neuroscience 4:224–37. doi:10.1212/01.wnl.0000138438.88589.7c.
   Google Scholar
• Dohmen, Thomas J., Armin Falk, David Huffman, Uwe Sunde, Jürgen Schupp, and Gert G. Wagner. 2005. “Individual Risk Attitudes: New Evidence from a Large, Representative, Experimentally-Validated Survey.” SSRN Electronic Journal 1730:1–56. doi:10.2139/ssrn.807408.
   Google Scholar
• Dresler, Martin, Anders Sandberg, Christoph Bublitz, Kathrin Ohla, Carlos Trenado, Aleksandra Mroczko-Wąsowicz, Simone Kühn, and Dimitris Repantis. 2019. “Hacking the Brain: Dimensions of Cognitive Enhancement.” ACS Chemical Neuroscience 10(3):1137–48. doi:10.1021/acschemneuro.8b00571.
   PubMed Web of Science ®Google Scholar
• Dresler, Martin, Anders Sandberg, Kathrin Ohla, Christoph Bublitz, Carlos Trenado, Aleksandra Mroczko-Wąsowicz, Simone Kühn, and Dimitris Repantis. 2013. “Non-Pharmacological Cognitive Enhancement.” Neuropharmacology, the Neuropharmacology of Social Behavior: From Bench to Bedside 64:529–43. doi:10.1016/j.neuropharm.2012.07.002.
   Google Scholar
• Dubljević, Veljko, Sebastian Sattler, and Éric Racine. 2014. “Cognitive Enhancement and Academic Misconduct: A Study Exploring Their Frequency and Relationship.” Ethics & Behavior 24(5):408–20. doi:10.1080/10508422.2013.869747.
   Web of Science ®Google Scholar
• Ernst, Edzard. 2002. “A Systematic Review of Systematic Reviews of Homeopathy.” British Journal of Clinical Pharmacology 54(6):577–82. doi:10.1046/j.1365-2125.2002.01699.x.
   PubMed Web of Science ®Google Scholar
• Farah, Martha J. 2015. “The Unknowns of Cognitive Enhancement.” Science 350(6259):379–80. doi:10.1126/science.aad5893.
   PubMed Web of Science ®Google Scholar
• Farah, Martha J., Judy Illes, Robert Cook-Deegan, Howard Gardner, Eric Kandel, Patricia King, Eric Parens, Barbara Sahakian, and Paul Root Wolpe. 2004. “Neurocognitive Enhancement: What Can We Do and What Should We Do?” Nature Reviews Neuroscience 5(5):421–25. doi:10.1038/nrn1390.
   PubMed Web of Science ®Google Scholar
• Faraone, Stephen V., Anthony L. Rostain, C. Brendan Montano, Oren Mason, Kevin M. Antshel, and Jeffrey H. Newcorn. 2020. “Systematic Review: Nonmedical Use of Prescription Stimulants: Risk Factors, Outcomes, and Risk Reduction Strategies.” Journal of the American Academy of Child & Adolescent Psychiatry 59(1):100–12. doi:10.1016/j.jaac.2019.06.012.
   PubMed Web of Science ®Google Scholar
• Federal Institute for Research on Building; Urban Affairs and Spatial Development. (2017). Referenz Gemeinden, Kreise, NUTS [ dataset]. https://www.inkar.de/documents/Referenz%20Gemeinden-GVB-Kreise_NUTS.xlsx.
   Google Scholar
• Ferguson, Christopher J. 2009. “An Effect Size Primer: A Guide for Clinicians and Researchers.” Professional Psychology: Research and Practice 40(5):532–38. doi:10.1037/a0015808.
   Web of Science ®Google Scholar
• Ferrari, Michel. 2011. “What Can Neuroscience Bring to Education?” Educational Philosophy and Theory 43(1):31–36. doi:10.1111/j.1469-5812.2010.00704.x.
   Web of Science ®Google Scholar
• Fink, George. 2016. “Fink G. Stress, Definitions, Mechanisms, and Effects Outlined: Lessons from Anxiety.” in Pp. 3–11 in Stress: Concepts, Cognition, Emotion, and Behavior, Volume 1 of the Handbook of Stress Series, edited by G. Fink. San Diego: Elsevier Inc
   Google Scholar
• Fitz, Nicholas S., Roland Nadler, Praveena Manogaran, Eugene WJ Chong, and Peter B. Reiner. 2014. “Public Attitudes Toward Cognitive Enhancement.” Neuroethics 7(2):173–88. doi:10.1007/s12152-013-9190-z.
   Web of Science ®Google Scholar
• Ford, Jason A. and Julianne Ong. 2014. “Non-Medical Use of Prescription Stimulants for Academic Purposes Among College Students: A Test of Social Learning Theory.” Drug and Alcohol Dependence 144:279–82. doi:10.1016/j.drugalcdep.2014.09.011.
   PubMed Web of Science ®Google Scholar
• Ford, J. A. and R. D. Schroeder. 2009. “Academic Strain and Non-Medical Use of Prescription Stimulants Among College Students.” Deviant Behavior 30:26–53. doi:10.1080/01639620802049900.
   Web of Science ®Google Scholar
• Ford, Jason A. and Alexis Yohros. 2018. “Understanding Nonmedical Prescription Drug Use: The Importance of Criminological Theory.” in p. 283 in The Prescription Drug Abuse Epidemic: Incidence, Treatment, Prevention, and Policy, edited by T. S. Schepis. Praeger.
   Google Scholar
• Forlini, Cynthia, Jan Schildmann, Patrik Roser, Radim Beranek, and Jochen Vollmann. 2015. “Knowledge, Experiences and Views of German University Students Toward Neuroenhancement: An Empirical-Ethical Analysis.” Neuroethics 8(2):83–92. doi:10.1007/s12152-014-9218-z.
   Web of Science ®Google Scholar
• Forsberg, Ellen-Marie, Clare Shelley-Egan, Erik Thorstensen, Laurens Landeweerd, and Bjorn Hofmann. 2017. “Ethical Concerns in HCE: The Examples of Cognitive Enhancing Drugs and Noninvasive Brain Stimulation.” Pp. 15–29 in Evaluating Ethical Frameworks for the Assessment of Human Cognitive Enhancement Applications. Springer.
   Google Scholar
• Franke, Andreas G. 2019. “Neuroenhancement Und Sucht.” Pp. 155–62 in Hirndoping & Co. Die optimierte Gesellschaft. Berlin, Heidelberg: Springer.
   Google Scholar
• Franke, Andreas G., Christiana Bagusat, Pavel Dietz, Isabell Hoffmann, Perikles Simon, Rolf Ulrich, and Klaus Lieb. 2013. “Use of Illicit and Prescription Drugs for Cognitive or Mood Enhancement Among Surgeons.” BMC Medicine 11(1):1–9. doi:10.1186/1741-7015-11-102.
   PubMedGoogle Scholar
• Franke, Andreas G., Christiana Bagusat, Carolyn McFarlane, Teresina Tassone-Steiger, Werner Kneist, and Klaus Lieb. 2015. “The Use of Caffeinated Substances by Surgeons for Cognitive Enhancement.” Annals of Surgery 261(6):1091–95. doi:10.1097/SLA.0000000000000830.
   PubMed Web of Science ®Google Scholar
• Franke, Andreas G., Caroline Bonertz, Michaela Christmann, Stefan Engeser, and Klaus Lieb. 2012. “Attitudes Toward Cognitive Enhancement in Users and Nonusers of Stimulants for Cognitive Enhancement: A Pilot Study.” AJOB Primary Research 3(1):48–57. doi:10.1080/21507716.2011.608411.
   Google Scholar
• Franke, Andreas G., Robert Northoff, and Elisabeth Hildt. 2015. “The Case of Pharmacological Neuroenhancement: Medical, Judicial and Ethical Aspects from a German Perspective.” Pharmacopsychiatry 48(7):256–64. doi:10.1055/s-0035-1559640.
   PubMed Web of Science ®Google Scholar
• Fuermaier, Anselm BM, Oliver Tucha, Janneke Koerts, Lara Tucha, Johannes Thome, and Frank Faltraco. 2021. “Feigning ADHD and Stimulant Misuse Among Dutch University Students.” Journal of Neural Transmission 128:1079–84. doi:10.1007/s00702-020-02296-7.
   PubMed Web of Science ®Google Scholar
• Galea, Sandro, Sasha Rudenstine, and David Vlahov. 2005. “Drug Use, Misuse, and the Urban Environment.” Drug and Alcohol Review 24(2):127–36. doi:10.1080/09595230500102509.
   PubMed Web of Science ®Google Scholar
• Gräff, Johannes and Li-Huei Tsai. 2013. “The Potential of HDAC Inhibitors As Cognitive Enhancers.” Annual Review of Pharmacology and Toxicology 53(1):311–30. doi:10.1146/annurev-pharmtox-011112-140216.
   PubMedGoogle Scholar
• Greely, Henry, Barbara Sahakian, John Harris, Roland C. Kessler, Michael Gazzaniga, Philip Campbell, and Martha J. Farah. 2008. “Towards Responsible Use of Cognitive Enhancing Drugs by the Healthy.” Nature 456(7223):702–05. doi:10.1038/456702a.
   PubMed Web of Science ®Google Scholar
• Häder, Sabine and Siegfried Gabler. 1998. “Ein Neues Stichprobendesign Für Telefonische Umfragen in Deutschland.” Pp. 69–88 in Telefonstichproben in Deutschland. Springer.
   Google Scholar
• Hagenaars, Aldi JM, Klaas De Vos, and M. Asghar Zaidi. 1994. “Poverty Statistics in the Late 1980s: Research Based on Micro-Data.”
   Google Scholar
• Hahn, Britta, Cory K. Olmstead, Marie B. Yuille, Joshua J. Chiappelli, and Ashleigh K. Wells. 2020. “Attention-Enhancing Effects of Propranolol and Synergistic Effects with Nicotine.” Cognitive, Affective, & Behavioral Neuroscience 20(3):658–68. doi:10.3758/s13415-020-00794-5.
   PubMed Web of Science ®Google Scholar
• Hauser, Tobias U., Michael Moutoussis, Nina Purg, Peter Dayan, and Raymond J. Dolan. 2018. “Beta-Blocker Propranolol Modulates Decision Urgency During Sequential Information Gathering.” The Journal of Neuroscience 38(32):7170–78. doi:10.1523/JNEUROSCI.0192-18.2018.
   PubMed Web of Science ®Google Scholar
• Heller, Sebastian, Ana Nanette Tibubos, Thilo A. Hoff, Antonia M. Werner, Jennifer L. Reichel, Lina M. Mülder, Markus Schäfer, Daniel Pfirrmann, Birgit Stark, Thomas Rigotti, et al. 2022. “Potential Risk Groups and Psychological, Psychosocial, and Health Behavioral Predictors of Pharmacological Neuroenhancement Among University Students in Germany.” Scientific Reports 12(1):937. doi:10.1038/s41598-022-04891-y.
   PubMed Web of Science ®Google Scholar
• Hildt, Elisabeth. 2013. “Cognitive Enhancement – A Critical Look at the Recent Debate.” Pp. 1–14 in Cognitive enhancement. Springer.
   Google Scholar
• Hiltrop, Kati and Sebastian Sattler. 2022. “Parents’ Perceptions on the Debated Parenting Practice of Cognitive Enhancement in Healthy Children and Adolescents.” Journal of Cognitive Enhancement 6:373–88. doi:10.1007/s41465-022-00243-w.
   Google Scholar
• Hoebel, J., P. Kamtsiuris, C. Lange, S. Müters, R. Schilling, and E. von der Lippe. 2011. Ergebnisbericht: KOLIBRI-Studie Zum Konsum Leistungsbeeinflussender Mittel in Alltag Und Freizeit. Berlin: RKI.
   Google Scholar
• Huber, Saskia, Sebastian Sattler, and Guido Mehlkop. 2023. “Mechanisms of perceived social norms: the mediating and moderating role of morality and outcome expectations on prescription drug misuse in the working population.” Deviant Behavior 4(3):359–80. doi:10.1080/01639625.2022.2046981.
   Google Scholar
• Ilieva, Irena, Joseph Boland, and Martha J. Farah. 2013. “Objective and Subjective Cognitive Enhancing Effects of Mixed Amphetamine Salts in Healthy People.” Neuropharmacology, the Neuropharmacology of Social Behavior: From Bench to Bedside 64:496–505. doi:10.1016/j.neuropharm.2012.07.021.
   Google Scholar
• Irwin, Christopher, Saman Khalesi, Ben Desbrow, and Danielle McCartney. 2020. “Effects of Acute Caffeine Consumption Following Sleep Loss on Cognitive, Physical, Occupational and Driving Performance: A Systematic Review and Meta-Analysis.” Neuroscience & Biobehavioral Reviews 108:877–88. doi:10.1016/j.neubiorev.2019.12.008.
   PubMed Web of Science ®Google Scholar
• Jain, Parul and Raymond Humienny. 2020. “Normative Influences on the Role of Prescription Medicine Misuse Among College Students in the United States.” Health Communication 35(3):331–40. doi:10.1080/10410236.2018.1563029.
   PubMed Web of Science ®Google Scholar
• Jane, Emma and Nicole Vincent. 2017. “Cognitive Enhancement: A Social Experiment with Technology.” in Pp. 141–64 in New Perspectives on Technology in Society Experimentation Beyond the Laboratory, edited by I. van de Poel, L. Asveld, and D. C. Mehos. London: Routlege.
   Google Scholar
• Jang, Bohyun Joy, Megan S. Schuler, Rebecca J. Evans-Polce, and Megan E. Patrick. 2018. “Marital Status as a Partial Mediator of the Associations Between Young Adult Substance Use and Subsequent Substance Use Disorder: Application of Causal Inference Methods.” Journal of Studies on Alcohol and Drugs 79(4):567–77. doi:10.15288/jsad.2018.79.567.
   PubMed Web of Science ®Google Scholar
• Johnston, Lloyd D., Richard A. Miech, Patrick M. O’Malley, Jerald G. Bachman, John E. Schulenberg, and Megan E. Patrick. 2019. Monitoring the Future National Survey Results on Drug Use 1975-2018: Overview, Key Findings on Adolescent Drug Use. Ann Arbor: Institute for Social Research. The University of Michigan.
   Google Scholar
• Jones, Barry T., Will Corbin, and Kim Fromme. 2001. “A Review of Expectancy Theory and Alcohol Consumption.” Addiction 96(1):57–72. doi:10.1046/j.1360-0443.2001.961575.x.
   PubMed Web of Science ®Google Scholar
• Kandel, Denise and Eric Kandel. 2015. “The Gateway Hypothesis of Substance Abuse: Developmental, Biological and Societal Perspectives.” Acta Paediatrica 104(2):130–37. doi:10.1111/apa.12851.
   PubMed Web of Science ®Google Scholar
• Khantzian, Edward J. 1997. “The Self-Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications.” Harvard Review of Psychiatry 4(5):231–44. doi:10.3109/10673229709030550.
   PubMed Web of Science ®Google Scholar
• Kolenikov, Stanislav. 2014. “Calibrating Survey Data Using Iterative Proportional Fitting (Raking).” The Stata Journal 14(1):22–59. doi:10.1177/1536867X1401400104.
   Web of Science ®Google Scholar
• Kreuter, Frauke, Stanley Presser, and Roger Tourangeau. 2008. “Social Desirability Bias in CATI, IVR, and Web Surveys: The Effects of Mode and Question Sensitivity.” Public Opinion Quarterly 72(5):847–65. doi:10.1093/poq/nfn063.
   Web of Science ®Google Scholar
• Krumpal, Ivar. 2013. “Determinants of Social Desirability Bias in Sensitive Surveys: A Literature Review.” Quality & Quantity 47(4):2025–47. doi:10.1007/s11135-011-9640-9.
   Web of Science ®Google Scholar
• Laub, John H., Daniel S. Nagin, and Robert J. Sampson. 1998. “Trajectories of Change in Criminal Offending: Good Marriages and the Desistance Process.” American Sociological Review 63(2):225–38. doi:10.2307/2657324.
   Web of Science ®Google Scholar
• Lea, Toby, Nicole Amada, Henrik Jungaberle, Henrike Schecke, and Michael Klein. 2020. “Microdosing Psychedelics: Motivations, Subjective Effects and Harm Reduction.” International Journal of Drug Policy 75:102600. doi:10.1016/j.drugpo.2019.11.008.
   PubMed Web of Science ®Google Scholar
• Leon, Matthew R., Peter D. Harms, and Declan O. Gilmer. 2019. “PCE Use in the Workplace: The Open Secret of Performance Enhancement.” Journal of Management Inquiry 28(1):67–70. doi:10.1177/1056492618790091.
   Web of Science ®Google Scholar
• Lipman, Arthur G. 2004. The Federal Ban on Ephedrine Dietary Supplements: An Important Event for Pain Practitioners and PatientsVol. 18 Taylor & Francis.
   Google Scholar
• Long, J. Scott and Jeremy Freese. 2001. Regression Models for Categorical and Limited Dependent Variables Using Stata. Thousand Oaks, London and New Delhi: Sage Publications.
   Google Scholar
• Maier, Larissa J., Jason A. Ferris, and Adam R. Winstock. 2018. “Pharmacological Cognitive Enhancement Among Non-ADHD Individuals – A Cross-Sectional Study in 15 Countries.” International Journal of Drug Policy 58:104–12. doi:10.1016/j.drugpo.2018.05.009.
   PubMed Web of Science ®Google Scholar
• Maier, Larissa J., Severin Haug, and Michael P. Schaub. 2015. “The Importance of Stress, Self-Efficacy, and Self-Medication for Pharmacological Neuroenhancement Among Employees and Students.” Drug and Alcohol Dependence 156:221–27. doi:10.1016/j.drugalcdep.2015.09.012.
   PubMed Web of Science ®Google Scholar
• Maier, Larissa J., Severin Haug, and Michael P. Schaub. 2016. “Prevalence of and Motives for Pharmacological Neuroenhancement in Switzerland – Results from a National Internet Panel.” Addiction 111(2):280–95. doi:10.1111/add.13059.
   PubMed Web of Science ®Google Scholar
• Marschall, Jörg, Hans-Dieter Nolting, Susanne Hildebrandt, and Hanna Sydow. 2015. “Gesundheitsreport 2015. Analyse Der Arbeitsunfähigkeitsdaten. Update: Doping Am Arbeitsplatz.” Berlin/Hamburg: DAK/IGES.
   Google Scholar
• McCabe, Sean Esteban, James A. Cranford, Michele Morales, and Amy Young. 2006. “Simultaneous and Concurrent Polydrug Use of Alcohol and Prescription Drugs: Prevalence, Correlates, and Consequences.” Journal of Studies on Alcohol 67(4):529–37. doi:10.15288/jsa.2006.67.529.
   PubMed Web of Science ®Google Scholar
• McCabe, Sean Esteban, John R. Knight, Christian J. Teter, and Henry Wechsler. 2005. “Non-Medical Use of Prescription Stimulants Among US College Students: Prevalence and Correlates from a National Survey.” Addiction 100(1):96–106. doi:10.1111/j.1360-0443.2005.00944.x.
   PubMed Web of Science ®Google Scholar
• McCabe, Sean Esteban and Christian J. Teter. 2007. “Drug Use Related Problems Among Nonmedical Users of Prescription Stimulants: A Web-Based Survey of College Students from a Midwestern University.” Drug and Alcohol Dependence 91(1):69–76. doi:10.1016/j.drugalcdep.2007.05.010.
   PubMed Web of Science ®Google Scholar
• McCabe, Sean Esteban, Christian J. Teter, Carol J. Boyd, Timothy E. Wilens, and Ty S. Schepis. 2018. “Sources of Prescription Medication Misuse Among Young Adults in the United States: The Role of Educational Status.” The Journal of Clinical Psychiatry 79(2):2–18. doi:10.4088/JCP.17m11958.
   Web of Science ®Google Scholar
• Mears, Daniel P., Matthew Ploeger, and Mark Warr. 1998. “Explaining the Gender Gap in Delinquency: Peer Influence and Moral Evaluations of Behavior.” Journal of Research in Crime and Delinquency 35(3):251–66. doi:10.1177/0022427898035003001.
   Web of Science ®Google Scholar
• Metzler, Claudia. 2003. “Epidemiologie Des Substanzkonsums Bei Jugendlichen: Eine Analyse Unter Stadt-Land-Perspektive.” Katholische Fachhochschule Nordrhein-Westfalen.
   Google Scholar
• Middendorf, Elke, Jonas Poskowsky, and Karsten Becker. 2015. Formen Der Stresskompensation Und Leistungssteigerung Bei Studierenden. Hannover: DZHW.
   Google Scholar
• Miech, Richard, Lloyd Johnston, Patrick M. O’Malley, Katherine M. Keyes, and Kennon Heard. 2015. “Prescription Opioids in Adolescence and Future Opioid Misuse.” Pediatrics 136(5):e1169–77. doi:10.1542/peds.2015-1364.
   PubMed Web of Science ®Google Scholar
• Molloy, Brianne K., Michelle L. Stock, Tonya Dodge, and Julia G. Aspelund. 2019. “Predicting Future Academic Willingness, Intentions, and Nonmedical Prescription Stimulant (NPS) Use with the Theory of Reasoned Action and Prototype/Willingness Model.” Substance Use & Misuse 54(14):2251–63. doi:10.1080/10826084.2019.1645175.
   PubMed Web of Science ®Google Scholar
• Müller, Christian P. and Gunter Schumann. 2011. “Drugs As Instruments: A New Framework for Non-Addictive Psychoactive Drug Use.” Behavioral and Brain Sciences 34(6):293–310. doi:10.1017/S0140525X11000057.
   PubMed Web of Science ®Google Scholar
• Neubauer, Aljoscha C. and Guilherme Wood. 2022. “‘Intelligenzsteigerung Durch Neuroenhancement?’ Psychologische Rundschau.” Psychologische Rundschau 73(3):190–203. doi:10.1026/0033-3042/a000599.
   Google Scholar
• Nochaiwong, S., Chidchanok Ruengorn, Ratanaporn Awiphan, Chatree Chai-Adisaksopha, Apichat Tantraworasin, Chabaphai Phosuya, Penkarn Kanjanarat, Wilaiwan Chongruksut, Manish M. Sood, and Kednapa Thavorn. 2022. “Use of Serotonin Reuptake Inhibitor Antidepressants and the Risk of Bleeding Complications in Patients on Anticoagulant or Antiplatelet Agents: A Systematic Review and Meta-Analysis.” Annals of Medicine 54(1):80–97. doi:10.1080/07853890.2021.2017474.
   PubMed Web of Science ®Google Scholar
• Novak, Scott P., Anders Håkansson, Jose Martinez-Raga, Jens Reimer, Karol Krotki, and Sajan Varughese. 2016. “Nonmedical Use of Prescription Drugs in the European Union.” BMC Psychiatry 16(1):274. doi:10.1186/s12888-016-0909-3.
   PubMed Web of Science ®Google Scholar
• Novak, Scott P., Larry A. Kroutil, Rick L. Williams, and David L. Van Brunt. 2007. “The Nonmedical Use of Prescription ADHD Medications: Results from a National Internet Panel.” Substance Abuse Treatment, Prevention, and Policy 2(1):1–17. doi:10.1186/1747-597X-2-32.
   PubMedGoogle Scholar
• O’Connor, Cliodhna and Saskia K. Nagel. 2017. “Neuro-Enhancement Practices Across the Lifecourse: Exploring the Roles of Relationality and Individualism.” Frontiers in Sociology 2:1. doi:10.3389/fsoc.2017.00001.
   Google Scholar
• Ong, A. D. and D. J. Weiss. 2000. “The Impact of Anonymity on Responses to Sensitive Questions1.” Journal of Applied Social Psychology 30(8):1691–708. doi:10.1111/j.1559-1816.2000.tb02462.x.
   Web of Science ®Google Scholar
• Partridge, Brad, Stephanie K. Bell, Jayne C. Lucke, Sarah Yeates, and Wayne D. Hall. 2011. “Smart Drugs ‘As Common As Coffee’: Media Hype About Neuroenhancement.” Public Library of Science ONE 6(11):1–8. doi:10.1371/journal.pone.0028416.
   Google Scholar
• Patrzek, J., S. Sattler, F. van Veen, C. Grunschel, and S. Fries. 2015. “Investigating the Effect of Academic Procrastination on the Frequency and Variety of Academic Misconduct: A Panel Study.” Studies in Higher Education 40(6):1014–29. doi:10.1080/03075079.2013.854765.
   Web of Science ®Google Scholar
• Petranker, Rotem, Thomas Anderson, Larissa J. Maier, Monica J. Barratt, Jason A. Ferris, and Adam R. Winstock. 2022. “Microdosing Psychedelics: Subjective Benefits and Challenges, Substance Testing Behavior, and the Relevance of Intention.” Journal of Psychopharmacology 36(1):85–96. doi:10.1177/0269881120953994.
   PubMed Web of Science ®Google Scholar
• Ponnet, Koen, Edwin Wouters, Michel Walrave, Wannes Heirman, and Guido Van Hal. 2015. “Predicting Students’ Intention to Use Stimulants for Academic Performance Enhancement.” Substance Use & Misuse 50(3):275–82. doi:10.3109/10826084.2014.952446.
   PubMed Web of Science ®Google Scholar
• Popp, Maria, Miriam Stegemann, Maria-Inti Metzendorf, Susan Gould, Peter Kranke, Patrick Meybohm, Nicole Skoetz, and Stephanie Weibel. 2021. “Ivermectin for Preventing and Treating COVID‐19.” Cochrane Database of Systematic Reviews 7. doi: 10.1002/14651858.CD015017.
   Web of Science ®Google Scholar
• Racine, Eric, Sebastian Sattler, and Wren Boehlen. 2021. “Cognitive Enhancement: Unanswered Questions About Human Psychology and Social Behavior.” Science and Engineering Ethics 27. doi: 10.1007/s11948-021-00294-w.
   Web of Science ®Google Scholar
• Ragan, C. Ian, Imre Bard, and Ilina Singh. 2013. “What Should We Do About Student Use of Cognitive Enhancers? An Analysis of Current Evidence.” Neuropharmacology, the Neuropharmacology of Social Behavior: From Bench to Bedside 64:588–95. doi:10.1016/j.neuropharm.2012.06.016.
   Google Scholar
• Rauschert, C., J. Möckl, N. Wilms, E. Hoch, L. Kraus, and S. Olderbak. 2023a. Kurzbericht Epidemiologischer Suchtsurvey 2021. Tabellenband: Trends Der Prävalenz Des (Problematischen) Konsums Illegaler Drogen Nach Geschlecht Und Alter 1990-2021. Munich: IFT Institut für Therapieforschung.
   Google Scholar
• Rauschert, C., J. Möckl, N. Wilms, E. Hoch, L. Kraus, and S. Olderbak. 2023b. Kurzbericht Epidemiologischer Suchtsurvey 2021. Tabellenband: Trends Der Prävalenz Des (Problematischen) Medikamentenkonsums Nach Geschlecht Und Alter 1995-2021. Munich: IFT Institut für Therapieforschung.
   Google Scholar
• Repantis, Dimitris, Peter Schlattmann, Oona Laisney, and Isabella Heuser. 2010. “Modafinil and Methylphenidate for Neuroenhancement in Healthy Individuals: A Systematic Review.” Pharmacological Research 62(3):187–206. doi:10.1016/j.phrs.2010.04.002.
   PubMed Web of Science ®Google Scholar
• Rimal, Rajiv N., Maria K. Lapinski, Rachel J. Cook, and Kevin Real. 2005. “Moving Toward a Theory of Normative Influences: How Perceived Benefits and Similarity Moderate the Impact of Descriptive Norms on Behaviors.” Journal of Health Communication 10(5):433–50. doi:10.1080/10810730591009880.
   PubMed Web of Science ®Google Scholar
• Rimal, Rajiv N. and Kevin Real. 2005. “How Behaviors Are Influenced by Perceived Norms: A Test of the Theory of Normative Social Behavior.” Communication Research 32(3):389–414. doi:10.1177/0093650205275385.
   Web of Science ®Google Scholar
• Roberts, Carl A., Andrew Jones, Harry Sumnall, Suzanne H. Gage, and Catharine Montgomery. 2020. “How Effective Are Pharmaceuticals for Cognitive Enhancement in Healthy Adults? A Series of Meta-Analyses of Cognitive Performance During Acute Administration of Modafinil, Methylphenidate and D-Amphetamine.” European Neuropsychopharmacology 38:40–62. doi:10.1016/j.euroneuro.2020.07.002.
   PubMed Web of Science ®Google Scholar
• Sattler, S. 2016. “Cognitive Enhancement in Germany: Prevalence, Attitudes, Terms, Legal Status, and the Ethics Debate.” in Pp. 159–80 in Cognitive Enhancement: Ethical and Policy Implications in International Perspectives, edited by F. Jotterand and V. Dubljević. Oxford: OUP
   Google Scholar
• Sattler, Sebastian. 2019. “Nonmedical Use of Prescription Drugs for Cognitive Enhancement as Response to Chronic Stress Especially When Social Support Is Lacking.” Stress and Health 35(2):127–37. doi:10.1002/smi.2846.
   PubMed Web of Science ®Google Scholar
• Sattler, Sebastian. 2020. “Cognitive Enhancement in Children by Using Prescription Drugs.” in Educating 21st Century Children, edited by T. Burns and F. Gottschalk. Paris: OECD.
   Google Scholar
• Sattler, Sebastian, Cynthia Forlini, Éric Racine, Carsten Sauer, and Q. Sun. 2013. “Impact of Contextual Factors and Substance Characteristics on Perspectives Toward Cognitive Enhancement.” Public Library of Science ONE 8(8):e71452. doi:10.1371/journal.pone.0071452.
   Google Scholar
• Sattler, Sebastian, Guido Mehlkop, Peter Graeff, and Carsten Sauer. 2014. “Evaluating the Drivers of and Obstacles to the Willingness to Use Cognitive Enhancement Drugs: The Influence of Drug Characteristics, Social Environment, and Personal Characteristics.” Substance Abuse Treatment, Prevention, and Policy 9(1):8. doi:10.1186/1747-597X-9-8.
   PubMed Web of Science ®Google Scholar
• Sattler, Sebastian, Carsten Sauer, Guido Mehlkop, Peter Graeff, and M. Taffe. 2013. “The Rationale for Consuming Cognitive Enhancement Drugs in University Students and Teachers.” Public Library of Science ONE 8(7):e68821. doi:10.1371/journal.pone.0068821.
   Google Scholar
• Sattler, Sebastian and Reinhard Schunck. 2016. “Associations Between the Big Five Personality Traits and the Non-Medical Use of Prescription Drugs for Cognitive Enhancement.” Frontiers in Psychology 6:1971. doi:10.3389/fpsyg.2015.01971.
   PubMed Web of Science ®Google Scholar
• Sattler, Sebastian and Constantin Wiegel. 2013. “Cognitive Test Anxiety and Cognitive Enhancement: The Influence of Students’ Worries on Their Use of Performance-Enhancing Drugs.” Substance Use & Misuse 48(3):220–32. doi:10.3109/10826084.2012.751426.
   PubMed Web of Science ®Google Scholar
• Schäfer, Markus. 2018. Medienhype’Hirndoping’?: Die Rolle Der Journalisten in Der Gesellschaftlichen Debatte Um Neuroenhancement. Vol. 18. Nomos Verlag.
   Google Scholar
• Schäfer, Markus. 2020. “Pharmakologisches Neuroenhancement in Deutschland.” Suchttherapie 21(3):148–56. doi:10.1055/a-1059-3751.
   Google Scholar
• Schelle, Kimberly J., Nadira Faulmüller, Lucius Caviola, and Miles Hewstone. 2014. “Attitudes Toward Pharmacological Cognitive Enhancement – A Review.” Frontiers in Systems Neuroscience 8:1–14. doi:10.3389/fnsys.2014.00053.
   PubMedGoogle Scholar
• Schelle, Kimberly J., Bas MJ Olthof, Wesley Reintjes, Carsten Bundt, Joyce Gusman-Vermeer, and Anke CCM Van Mil. 2015. “A Survey of Substance Use for Cognitive Enhancement by University Students in the Netherlands.” Frontiers in Systems Neuroscience 9:10. doi:10.3389/fnsys.2015.00010.
   PubMed Web of Science ®Google Scholar
• Scheske, Christel and Simone Schnall. 2012. “The Ethics of “Smart Drugs”: Moral Judgments About Healthy People’s Use of Cognitive-Enhancing Drugs.” Basic and Applied Social Psychology 34(6):508–15. doi:10.1080/01973533.2012.711692.
   Web of Science ®Google Scholar
• Schmitt, J. A. J., M. Wingen, J. G. Ramaekers, E. A. T. Evers, and W. J. Riedel. 2006. “Serotonin and Human Cognitive Performance.” Current Pharmaceutical Design 12(20):2473–86. doi:10.2174/138161206777698909.
   PubMed Web of Science ®Google Scholar
• Schröder, Helmut, Thorsten Köhler, Petra Knerr, D. Moesgen Simon Kühne, and M. Klein. 2015. Einfluss Psychischer Belastungen Am Arbeitsplatz Auf Das Neuroenhancement. Dortmund: Bundesanstalt für Arbeitsschutz und Arbeitsmedizin.
   Google Scholar
• Siegrist, Johannes. 2016. “Effort-Reward Imbalance Model.” in Pp. 81–86 in Stress: Concepts, Cognition, Emotion, and Behavior, edited by G. Fink. Academic Press.
   Google Scholar
• Singh, Ilina, Imre Bard, and Jonathan Jackson. 2014. “Robust Resilience and Substantial Interest: A Survey of Pharmacological Cognitive Enhancement Among University Students in the UK and Ireland.” Public Library of Science ONE 9(10):e105969. doi:10.1371/journal.pone.0105969.
   Google Scholar
• Smith, Elisabeth M. and Martha J. Farah. 2011. “Are Prescription Stimulants ‘Smart Pills’? The Epidemiology and Cognitive Neuroscience of Prescription Stimulant Use by Normal Healthy Individuals.” Psychological Bulletin 137(5):717–41. doi:10.1037/a0023825.
   PubMed Web of Science ®Google Scholar
• Statista. 2020. “Haushalte in Deutschland – Internetzugang bis 2019.” Retrieved July 8, 2020 (https://de.statista.com/statistik/daten/studie/153257/umfrage/haushalte-mit-internetzugang-in-deutschland-seit-2002).
   Google Scholar
• Sullivan, Gail M. and Richard Feinn. 2012. “Using Effect Size – Or Why the P Value Is Not Enough.” Journal of Graduate Medical Education 4(3):279–82. doi:10.4300/JGME-D-12-00156.1.
   PubMedGoogle Scholar
• Tantcheva-Poór, Iliana, Michael Zaigler, Stephan Rietbrock, and Uwe Fuhr. 1999. “Estimation of Cytochrome P-450 CYP1A2 Activity in 863 Healthy Caucasians Using a Saliva-Based Caffeine Test.” Pharmacogenetics 9(2):131–44.
   PubMedGoogle Scholar
• Teter, Christian J., Christopher G. DiRaimo, Brady T. West, Ty S. Schepis, and Sean Esteban McCabe. 2020. “Nonmedical Use of Prescription Stimulants Among US High School Students to Help Study: Results from a National Survey.” Journal of Pharmacy Practice 33(1):38–47. doi:10.1177/0897190018783887.
   PubMed Web of Science ®Google Scholar
• Thoits, Peggy A. 2011. “Mechanisms Linking Social Ties and Support to Physical and Mental Health.” Journal of Health and Social Behavior 52(2):145–61. doi:10.1177/0022146510395592.
   PubMed Web of Science ®Google Scholar
• Thompson, Lisa, Amy Pennay, Adam Zimmermann, Merrilee Cox, and Dan I. Lubman. 2014. “‘Clozapine Makes Me Quite Drowsy, so When I Wake Up in the Morning Those First Cups of Coffee Are Really Handy’: An Exploratory Qualitative Study of Excessive Caffeine Consumption Among Individuals with Schizophrenia.” BMC Psychiatry 14(1):1–10. doi:10.1186/1471-244X-14-116.
   Google Scholar
• van Veen, Floris, Sebastian Sattler, Guido Mehlkop, and Fabian Hasselhorn. 2021. “Feigning Symptoms to Obtain Prescription Stimulants: A Vignette-Based Study on Its Conditions.” Journal of Drug Issues 52(2):225–49. doi:10.1177/00220426211055433.
   Web of Science ®Google Scholar
• Vargo, Elisabeth J. and Andrea Petróczi. 2016. “‘It Was Me on a Good Day’: Exploring the Smart Drug Use Phenomenon in England.” Frontiers in Psychology 7:779. doi:10.3389/fpsyg.2016.00779.
   PubMed Web of Science ®Google Scholar
• Weyandt, Lisa L., Grace Janusis, Kimberly G. Wilson, Genevieve Verdi, Gregory Paquin, Justin Lopes, Michael Varejao, and Crystal Dussault. 2009. “Nonmedical Prescription Stimulant Use Among a Sample of College Students: Relationship with Psychological Variables.” Journal of Attention Disorders 13(3):284–96. doi:10.1177/1087054709342212.
   PubMed Web of Science ®Google Scholar
• Weyandt, Lisa L., Tara L. White, Bergljot Gyda Gudmundsdottir, Adam Z. Nitenson, Emma S. Rathkey, Kelvin A. De Leon, and Stephanie A. Bjorn. 2018. “Neurocognitive, Autonomic, and Mood Effects of Adderall: A Pilot Study of Healthy College Students.” Pharmacy 6(3):58. doi:10.3390/pharmacy6030058.
   Web of Science ®Google Scholar
• Wiegel, Constantin, Sebastian Sattler, Anja S. Göritz, and Martin Diewald. 2016. “Work-Related Stress and Cognitive Enhancement Among University Teachers.” Anxiety, Stress, & Coping 29(1):100–17. doi:10.1080/10615806.2015.1025764.
   PubMed Web of Science ®Google Scholar
• Winder-Rhodes, Sophie E., Samuel R. Chamberlain, Mohamad I. Idris, Trevor W. Robbins, Barbara J. Sahakian, and Ulrich Mueller-Sedgwick. 2010. “Effects of Modafinil and Parazosin on Cognitive and Physiological Functions in Healthy Volunteers.” Journal of Psychopharmacology 24(11):1649–57. doi:10.1177/0269881109105899.
   PubMed Web of Science ®Google Scholar
• Winkler, Alexander and Christiane Hermann. 2019. “Placebo-And Nocebo-Effects in Cognitive Neuroenhancement: When Expectation Shapes Perception.” Frontiers in Psychiatry 10:498. doi:10.3389/fpsyt.2019.00498.
   PubMed Web of Science ®Google Scholar
• Wolff, Wanja and Ralf Brand. 2013. “Subjective Stressors in School and Their Relation to Neuroenhancement: A Behavioral Perspective on Students’ Everyday Life ‘Doping’.” Substance Abuse Treatment, Prevention, and Policy 8(1):23. doi:10.1186/1747-597X-8-23.
   PubMedGoogle Scholar
• Yartsev, Alex and Carmelle Peisah. 2021. “Caffeine-Clozapine Interaction Associated with Severe Toxicity and Multiorgan System Failure: A Case Report.” BMC Psychiatry 21(1):1–5. doi:10.1186/s12888-021-03199-x.
   PubMed Web of Science ®Google Scholar
• Zimmerman, Gregory M. and Steven F. Messner. 2010. “Neighborhood Context and the Gender Gap in Adolescent Violent Crime.” American Sociological Review 75(6):958–80. doi:10.1177/0003122410386688.
   PubMed Web of Science ®Google Scholar
• Zohny, Hazem. 2015. “The Myth of Cognitive Enhancement Drugs.” Neuroethics 8(3):257–69. doi:10.1007/s12152-015-9232-9.
   Web of Science ®Google Scholar